Alzheimer’s drug slows progression of disease in global study

Yahoo News Video
1 年前

Experts are hopeful after lecanemab, an experimental drug, slowed the cognitive decline of Alzheimer's by 27% in a global clinical study. The study included 1,795 diverse patients with early stage Alzheimer’s.